D Siegal, J Curnutte, S Connolly, et al N Eng J Med, 2015, online first
In August we breathed a sigh of relief with the publication of the success of idarucizumab for the reversal of the direct thrombin inhibitor This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register
Paper
Readers Comments - 0
Recent Comments
Past Months
Library
No Comments yet.
Become a member
Comment
In August we breathed a sigh of relief with the publication of the success of idarucizumab for the reversal of the direct thrombin inhibitor
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register